Fri, October 22, 2010
Thu, October 21, 2010
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ]: Market Wire
STJ, AGAM, BAC, MDT, BSX
Tue, October 19, 2010
Mon, October 18, 2010
Sun, October 17, 2010
Sat, October 16, 2010
Fri, October 15, 2010
[ Fri, Oct 15th 2010 ]: Market Wire
ALGN, FCN, GOOG, SWY, GCI
Thu, October 14, 2010
Wed, October 13, 2010
Tue, October 12, 2010
Mon, October 11, 2010
[ Mon, Oct 11th 2010 ]: Market Wire
SNY,GENZ,LH,AVB,MU
[ Mon, Oct 11th 2010 ]: Market Wire
ARAY,SI,VAR,TOMO,JMBA
Sun, October 10, 2010
Sat, October 9, 2010
Fri, October 8, 2010
Thu, October 7, 2010
[ Thu, Oct 07th 2010 ]: Market Wire
30pm CST
Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
Sun, October 3, 2010
Fri, October 1, 2010
Thu, September 30, 2010

Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of King Pharmaceuticals, Inc.


  Copy link into your clipboard //health-fitness.news-articles.net/content/2010/ .. of-shareholders-of-king-pharmaceuticals-inc.html
  Print publication without navigation Published in Health and Fitness on by Market Wire


BENSALEM, Pa.--([ BUSINESS WIRE ])--Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of King Pharmaceuticals, Inc. (aKing Pharmaceuticalsa or the aCompanya) (NYSE:KG) related to the Companya™s agreement to be acquired by Pfizer Inc. (aPfizera). The proposed cash transaction is valued at approximately $3.6 billion.

Under the terms of the definitive merger agreement entered into by the parties, Pfizer will promptly commence a tender offer to purchase all of the outstanding shares of King Pharmaceuticals common stock for $14.25 per share in cash. If the tender offer is successfully completed, it is anticipated that the transaction will close by fourth quarter 2010 or first quarter 2011. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the proposed transaction by King Pharmaceuticalsa™ board of directors.

If you own shares of King Pharmaceuticals, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to [ howardsmith@howardsmithlaw.com ], or visit our website at [ http://www.howardsmithlaw.com ].


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear